AIM to AID, a nonprofit founded by Houston high school students, is launching an app to provide critical tools for refugees. Photo via Canva

A nonprofit founded by high school students in Houston is looking to provide tools to refugees at their fingertips.

AIM to AID, founded by children of immigrants to help ease the transition of immigrants and refugees to the United States, has announced the launch of its Merhaba app. The platform was created to be another tool for refugees in immersion through the convenience of a smartphone. The app is launching by March for Google Play and Apple.

Merhaba, which means “hi” in Arabic and is a general Middle Eastern greeting, aims to connect refugees to resources they need to be successful in the face of culture shock, and address any present day struggles a refugee would have when making the transition to a new life. Some of the features will include translation services, prayer compass to show Muslims the accurate direction in which to pray, and a halal finder for those to find businesses close to them that serve food that fits certain religious and dietary needs. The app also includes a tracker to find Mosques, Islamic and general clothing, bus stations, parks, banks, hospitals, and governmental offices.

The Houston-based organization was started by Lamar High School senior Ibraheem Razouki and DeBakey High School senior Zane Asadi, and is now in three continents with over 25 chapters internationally.

The first version of the app is tailored to Middle Eastern refugees, which makes the app unique in the marketplace. AIM to AID hopes as the app and the program grows, the features of the app will expand to serve the needs of diverse refugee populations.

Razouki came to the U.S. as a migrant during the Iraq war and recalls the struggle as a child to fit in because these resources weren’t available and the desperation that came with it. The application will provide mandatory needs and services to assist those of Middle Eastern and Muslim background with everyday needs.

“A lot of the needs that are being addressed in the app is a way of life for some of the refugees since they are deeply integrated into their religion, which is part of their identity,” says Razouki. ”Just having these conveniences at your disposable can enhance their way of life.”

In April, Ibraheem and other members of AIM to AID are going to Congress to pitch the application as a winner of the Congressional App Challenge.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”